80 related articles for article (PubMed ID: 15304366)
1. Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.
Tavallaie M; Chenal A; Gillet D; Pereira Y; Manich M; Gibert M; Raffestin S; Popoff MR; Marvaud JC
FEBS Lett; 2004 Aug; 572(1-3):299-306. PubMed ID: 15304366
[TBL] [Abstract][Full Text] [Related]
2. Protection with a recombinant Hc of Clostridium Botulinum neurotoxin serotype A from Escherichia coli as an effective subunit vaccine.
Yu YZ; Sun ZW; Li N; Wang S; Wang RL; Yu WY
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):261-6. PubMed ID: 18932057
[TBL] [Abstract][Full Text] [Related]
3. Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A.
Sharma S; Zhou Y; Singh BR
Protein Expr Purif; 2006 Feb; 45(2):288-95. PubMed ID: 16143544
[TBL] [Abstract][Full Text] [Related]
4. Improved soluble expression and characterization of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli by using a PCR-synthesized gene and a Trx co-expression strain.
Chen R; Shi J; Cai K; Tu W; Hou X; Liu H; Xiao L; Wang Q; Tang Y; Wang H
Protein Expr Purif; 2010 May; 71(1):79-84. PubMed ID: 19932180
[TBL] [Abstract][Full Text] [Related]
5. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate.
Yu YZ; Li N; Zhu HQ; Wang RL; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2009 May; 27(21):2816-22. PubMed ID: 19428892
[TBL] [Abstract][Full Text] [Related]
6. Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity.
Ozanich RM; Bruckner-Lea CJ; Warner MG; Miller K; Antolick KC; Marks JD; Lou J; Grate JW
Anal Chem; 2009 Jul; 81(14):5783-93. PubMed ID: 19530657
[TBL] [Abstract][Full Text] [Related]
7. [Modification and high level expression of protective antigen fragment of botulinum neurotoxin serotype A].
Wang H; Yin J
Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):544-7. PubMed ID: 15968986
[TBL] [Abstract][Full Text] [Related]
8. Recombinant expression and purification of the botulinum neurotoxin type A translocation domain.
Lacy DB; Stevens RC
Protein Expr Purif; 1997 Nov; 11(2):195-200. PubMed ID: 9367816
[TBL] [Abstract][Full Text] [Related]
9. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
[TBL] [Abstract][Full Text] [Related]
10. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.
Baldwin MR; Bradshaw M; Johnson EA; Barbieri JT
Protein Expr Purif; 2004 Sep; 37(1):187-95. PubMed ID: 15294297
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
Dolimbek GS; Dolimbek BZ; Aoki KR; Atassi MZ
Immunol Invest; 2005; 34(2):119-42. PubMed ID: 15921155
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
Yu YZ; Zhang SM; Sun ZW; Wang S; Yu WY
Vaccine; 2007 Dec; 25(52):8843-50. PubMed ID: 18022294
[TBL] [Abstract][Full Text] [Related]
13. Sequencing and phylogenetic analysis of neurotoxin gene from an environmental isolate of Clostridium sp.: comparison with other clostridial neurotoxins.
Dixit A; Alam SI; Singh L
Arch Toxicol; 2006 Jul; 80(7):399-404. PubMed ID: 16474961
[TBL] [Abstract][Full Text] [Related]
14. [Effective expression of fragments of a botulinum neurotoxin type A gene, coding for the L-chain and H-chain in E. coli, with formation of products causing protective immunity to administration of the toxin].
Vertiev IuV; Zdanovskiĭ AG; Borinskaia SA; Martin T; Gening EL; Iankovskiĭ NK
Mol Gen Mikrobiol Virusol; 2000; (4):3-7. PubMed ID: 11186457
[TBL] [Abstract][Full Text] [Related]
15. A sensitive sandwich enzyme immunoassay for free or complexed Clostridium botulinum neurotoxin type A.
Volland H; Lamourette P; Nevers MC; Mazuet C; Ezan E; Neuburger LM; Popoff M; Créminon C
J Immunol Methods; 2008 Jan; 330(1-2):120-9. PubMed ID: 18093612
[TBL] [Abstract][Full Text] [Related]
16. High-level expression, purification, and characterization of recombinant type A botulinum neurotoxin light chain.
Li L; Singh BR
Protein Expr Purif; 1999 Dec; 17(3):339-44. PubMed ID: 10600450
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
[TBL] [Abstract][Full Text] [Related]
19. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
[TBL] [Abstract][Full Text] [Related]
20. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3.
Webb RP; Smith TJ; Wright P; Brown J; Smith LA
Vaccine; 2009 Jul; 27(33):4490-7. PubMed ID: 19450643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
